Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroidectomy patients

Journal of Dermatological Treatment

Volumn 26, Issue 2, 2015, Pages 159-164

  Shin, Jung U ^a   Kang, Sang Wook ^b   Jeong, Jong Ju ^b   Nam, Kee Hyun ^b   Chung, Woong Youn ^b   Lee, Ju Hee ^a  

^a Yonsei University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Epidermal growth factor; Prevention; Scars

Indexed keywords

RECOMBINANT EPIDERMAL GROWTH FACTOR; RECOMBINANT HUMAN EPIDERMAL GROWTH FACTOR; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT; EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELASTICITY; ERYTHEMA; FEMALE; FOLLOW UP; HUMAN; HYDRATION; HYPERTROPHIC SCAR; PLIABILITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SKIN COLORIMETER; SKIN DISEASE ASSESSMENT; SKIN ELASTICITY METER; SKIN HYDRATION METER; SKIN PIGMENTATION; SKIN SCAR; SKINFOLD THICKNESS; THYROIDECTOMY; VANCOUVER SCAR SCALE; ADVERSE EFFECTS; CICATRIX; DRUG EFFECTS; MALE; MIDDLE AGED; PROCEDURES; WOUND HEALING;

ADULT; CICATRIX; EPIDERMAL GROWTH FACTOR; ERYTHEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; THYROIDECTOMY; WOUND HEALING;

EID: 84930792172     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2014.906034     Document Type: Article

References (51)

1. Terris DJ, Gourin CG, Chin E. Minimally invasive thyroidectomy: basic and advanced techniques. Laryngoscope. 2006;116:350-6.
2. Davies DM. Plastic and reconstructive surgery. Scars, hypertrophic scars, and keloids. Br Med J (Clin Res Ed). 1985;290:1056-8.
3. Rudolph R. Wide spread scars, hypertrophic scars, and keloids. Clin Plast Surg. 1987;14:253-60.
4. Slemp AE, Kirschner RE. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr. 2006;18:396-402.
5. Ahn ST, Monafo WW, Mustoe TA. Topical silicone gel: a new treatment for hypertrophic scars. Surgery. 1989;106:781-6; discussion 6-7.
6. Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol. 1994;30:506-7.
7. Willital GH, Heine H. Efficacy of Contractubex gel in the treatment of fresh scars after thoracic surgery in children and adolescents. Int J Clin Pharmacol Res. 1994;14:193-202.
8. Choe JH, Park YL, Kim BJ, et al. Prevention of thyroidectomy scar using a new 1550-nm fractional erbium-glass laser. Dermatol Surg. 2009;35:1199-205.
9. Jung JY, Jeong JJ, Roh HJ, et al. Early postoperative treatment of thyroidectomy scars using a fractional carbon dioxide laser. Dermatol Surg. 2011;37:217-23.
10. Yun JS, Choi YJ, Kim WS, Lee GY. Prevention of thyroidectomy scars in Asian adults using a 532-nm potassium titanyl phosphate laser. Dermatol Surg. 2011;37:1747-53.
11. Cass DL, Bullard KM, Sylvester KG, et al. Wound size and gestational age modulate scar formation in fetal wound repair. J Pediatr Surg. 1997;32:411-15.
12. Longaker MT, Whitby DJ, Adzick NS, et al. Studies in fetal wound healing, VI. Second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation. J Pediatr Surg. 1990;25:63-8; discussion 8-9.
13. Lorenz HP, Whitby DJ, Longaker MT, Adzick NS. Fetal wound healing. The ontogeny of scar formation in the non-human primate. Ann Surg. 1993;217:391-6.
14. Peled ZM, Rhee SJ, Hsu M, et al. The ontogeny of scarless healing II: EGF and PDGF-B gene expression in fetal rat skin and fibroblasts as a function of gestational age. Ann Plast Surg. 2001;47:417-24.
15. Nanney LB. Epidermal and dermal effects of epidermal growth factor during wound repair. J Invest Dermatol. 1990;94:624-9.
16. Brown GL, Curtsinger L III, Brightwell JR, et al. Enhancement of epidermal regeneration by biosynthetic epidermal growth factor. J Exp Med. 1986;163:1319-24.
17. Epstein JB, Gorsky M, Guglietta A, et al. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy. Cancer. 2000;89: 2258-65.
18. Kim YS, Lew DH, Tark KC, et al. Effect of recombinant human epidermal growth factor against cutaneous scar formation in murine full-thickness wound healing. J Korean Med Sci. 2010;25:589-96.
19. Satici A, Guzey M, Dogan Z, Kilic A. Relationship between Tear TNF-alpha, TGF-beta1, and EGF levels and severity of conjunctival cicatrization in patients with inactive trachoma. Ophthalmic Res. 2003;35:301-5.
20. Sullivan T, Smith J, Kermode J, et al. Rating the burn scar. J Burn Care Rehabil. 1990;11:256-60.
21. Baryza MJ, Baryza GA. The Vancouver Scar Scale: an administration tool and its interrater reliability. J Burn Care Rehabil. 1995;16: 535-8.
22. Noordenbos J, Dore C, Hansbrough JF. Safety and efficacy of TransCyte for the treatment of partial-thickness burns. J Burn Care Rehabil. 1999;20:275-81.
23. Sheridan R, Choucair R, Donelan M, et al. Acellular allodermis in burns surgery: 1-year results of a pilot trial. J Burn Care Rehabil. 1998;19:528-30.
24. Truong PT, Abnousi F, Yong CM, et al. Standardized assessment of breast cancer surgical scars integrating the Vancouver Scar Scale, Short-Form McGill Pain Questionnaire, and patients' perspectives. Plast Reconstr Surg. 2005;116:1291-9.
25. Alam M, Pon K, Van Laborde S, et al. Clinical effect of a single pulsed dye laser treatment of fresh surgical scars: randomized controlled trial. Dermatol Surg. 2006;32:21-5.
26. Bouzari N, Davis SC, Nouri K. Laser treatment of keloids and hypertrophic scars. Int J Dermatol. 2007;46:80-8.
27. Chan HH, Wong DS, Ho WS, et al. The use of pulsed dye laser for the prevention and treatment of hypertrophic scars in chinese persons. Dermatol Surg. 2004;30:987-94; discussion 94.
28. Nouri K, Elsaie ML, Vejjabhinanta V, et al. Comparison of the effects of short-and long-pulse durations when using a 585-nm pulsed dye laser in the treatment of new surgical scars. Lasers Med Sci. 2010;25:121-6.
29. Mackool RJ, Gittes GK, Longaker MT. Scarless healing. The fetal wound. Clin Plast Surg. 1998;25:357-65.
30. Siebert JW, Burd AR, McCarthy JG, et al. Fetal wound healing: a biochemical study of scarless healing. Plast Reconstr Surg. 1990;85: 495-502; discussion 3-4.
31. Leung A, Crombleholme TM, Keswani SG. Fetal wound healing: implications for minimal scar formation. Curr Opin Pediatr. 2012; 24:371-8.
32. Ellis IR, Schor SL. Differential motogenic and biosynthetic response of fetal and adult skin fibroblasts to TGF-beta isoforms. Cytokine. 1998;10:281-9.
33. Lin RY, Sullivan KM, Argenta PA, et al. Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair. Ann Surg. 1995; 222:146-54.
34. O'Kane S, Ferguson MW. Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol. 1997;29:63-78.
35. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci. 1995;108:985-1002.
36. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007;127: 514-25.
37. Stramer BM, Mori R, Martin P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol. 2007;127:1009-17.
38. Wong VW, Paterno J, Sorkin M, et al. Mechanical force prolongs acute inflammation via T-cell-dependent pathways during scar formation. FASEB J. 2011;25:4498-510.
39. Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis. 2010;30:245-57.
40. Wang J, Jiao H, Stewart TL, et al. Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen. 2007;15:530-9.
41. Wynn TA. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol. 2004;4:583-94.
42. Frantz FW, Bettinger DA, Haynes JH, et al. Biology of fetal repair: the presence of bacteria in fetal wounds induces an adult-like healing response. J Pediatr Surg. 1993;28:428-33; discussion 33-4.
43. Haynes JH, Johnson DE, Mast BA, et al. Platelet-derived growth factor induces fetal wound fibrosis. J Pediatr Surg. 1994; 29:1405-8.
44. Krummel TM, Nelson JM, Diegelmann RF, et al. Fetal response to injury in the rabbit. J Pediatr Surg. 1987;22:640-4.
45. Liechty KW, Adzick NS, Crombleholme TM. Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair. Cytokine. 2000;12:671-6.
46. Liechty KW, Crombleholme TM, Cass DL, et al. Diminished interleukin-8 (IL-8) production in the fetal wound healing response. J Surg Res. 1998;77:80-4.
47. Liechty KW, Kim HB, Adzick NS, Crombleholme TM. Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. J Pediatr Surg. 2000;35:866-72; discussion 72-3.
48. Martin P, D'Souza D, Martin J, et al.Wound healing in the PU.1 null mouse-tissue repair is not dependent on inflammatory cells. Curr Biol. 2003;13:1122-8.
49. Babul A, Gonul B, Dincer S, et al. The effect of EGF application in gel form on histamine content of experimentally induced wound in mice. Amino Acids. 2004;27:321-6.
50. Chen MA, Davidson TM. Scar management: prevention and treatment strategies. Curr Opin Otolaryngol Head Neck Surg. 2005;13:242-7.
51. Su CW, Alizadeh K, Boddie A, Lee RC. The problem scar. Clin Plast Surg. 1998;25:451-65.